Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.16B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.08B |
| 4 |
CME Group
CME
|
+$992M |
| 5 |
Booking.com
BKNG
|
+$960M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$1.14B |
| 2 |
Amazon
AMZN
|
+$1.09B |
| 3 |
Intercontinental Exchange
ICE
|
+$954M |
| 4 |
ServiceNow
NOW
|
+$930M |
| 5 |
NVIDIA
NVDA
|
+$855M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.64% |
| 2 | Financials | 10.94% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.94% |
| 5 | Industrials | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5101
Kewaunee Scientific
KEQU
$102M
| $683K | ﹤0.01% |
20,502
+12
| +0.1% | +$563 |
|
5102
WBI Power Factor High Dividend ETF
WBIY
$63.8M
| $681K | ﹤0.01% |
21,736
+7
| +0% | +$211 |
|
5103
Solid Power
SLDP
$477M
| $681K | ﹤0.01% |
504,118
+103,266
| +26% | +$163K |
|
5104
Wheels Up
UP
$207M
| $680K | ﹤0.01% |
14,060
-612
| -4% | -$29.9K |
|
5105
Invesco DB Precious Metals Fund
DBP
$249M
| $680K | ﹤0.01% |
10,654
-2
| -0% | -$120 |
|
5106
Hagerty
HGTY
$1.36B
| $679K | ﹤0.01% |
66,732
+15,604
| +31% | +$173K |
|
|
RPTX
5107
DELISTED
Repare Therapeutics
RPTX
| $677K | ﹤0.01% |
196,847
-98,913
| -33% | -$326K |
|
5108
Galectin Therapeutics
GALT
$198M
| $677K | ﹤0.01% |
246,080
+18,863
| +8% | +$46.3K |
|
5109
InfuSystem Holdings
INFU
$258M
| $676K | ﹤0.01% |
100,908
+32,316
| +47% | +$209K |
|
5110
Red River Bancshares
RRBI
$669M
| $676K | ﹤0.01% |
12,993
+7,501
| +137% | +$386K |
|
5111
iShares Global Timber & Forestry ETF
WOOD
$270M
| $675K | ﹤0.01% |
7,828
+399
| +5% | +$32.1K |
|
5112
Lifezone Metals
LZM
$350M
| $673K | ﹤0.01% |
96,101
+38,715
| +67% | +$271K |
|
5113
iShares MSCI Norway ETF
ENOR
$95M
| $671K | ﹤0.01% |
27,404
-1,124
| -4% | -$27.3K |
|
5114
Prelude Therapeutics
PRLD
$362M
| $670K | ﹤0.01% |
323,689
+36,335
| +13% | +$168K |
|
|
PIM
5115
Franklin Master Intermediate Income Trust
PIM
$151M
| $667K | ﹤0.01% |
196,738
+516
| +0.3% | +$1.72K |
|
5116
Monte Rosa Therapeutics
GLUE
$1.34B
| $664K | ﹤0.01% |
125,332
+56,990
| +83% | +$288K |
|
|
MBCN
5117
DELISTED
Middlefield Banc Corp
MBCN
| $664K | ﹤0.01% |
23,057
+12,451
| +117% | +$320K |
|
5118
ASP Isotopes
ASPI
$520M
| $663K | ﹤0.01% |
238,660
+107,943
| +83% | +$287K |
|
5119
Fidelity Enhanced Large Cap Growth ETF
FELG
$5.73B
| $663K | ﹤0.01% |
19,996
-1,146
| -5% | -$36.7K |
|
|
NRT
5120
North European Oil Royalty Trust
NRT
$81.3M
| $663K | ﹤0.01% |
126,287
-34,598
| -22% | -$202K |
|
5121
Trevi Therapeutics
TRVI
$2.65B
| $663K | ﹤0.01% |
198,480
+109,499
| +123% | +$325K |
|
5122
Dakota Gold
DC
$708M
| $662K | ﹤0.01% |
280,489
+170,241
| +154% | +$389K |
|
5123
Bel Fuse Inc Class A
BELFA
$3.46B
| $662K | ﹤0.01% |
6,653
+4,752
| +250% | +$413K |
|
5124
Dimensional International High Profitability ETF
DIHP
$6.47B
| $660K | ﹤0.01% |
23,837
+1,514
| +7% | +$40.7K |
|
5125
CervoMed
CRVO
$25.6M
| $659K | ﹤0.01% |
45,103
+37,436
| +488% | +$580K |
|
Similar funds
Morgan Stanley's Q3 2024 Portfolio in Review
As of Q3 2024, Morgan Stanley held 8,181 positions worth $1.38T, up 6.7% from $1.29T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q3 2024 filing shows 308 new, 3,869 increased, 2,774 reduced and 252 closed positions. Its largest new stake was Smurfit Westrock: 2,965,442 shares worth $147M. The largest sale was Adobe, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q3 2024 buy was Smurfit Westrock: 2,965,442 shares worth $147M.
- Morgan Stanley added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $1.74B increase.
- Morgan Stanley's biggest Q3 2024 reduction was Adobe, cutting an estimated $1.14B.
- Morgan Stanley fully exited WestRock Company in Q3 2024, selling an estimated $210M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.38T portfolio in Q3 2024.
- Morgan Stanley opened 308 new positions and closed 252 in Q3 2024.
- Morgan Stanley's portfolio value rose 6.7% quarter-over-quarter to $1.38T.
Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.